Description We welcome the best and brightest candidates to join our worldwide team. If you are desiring upgraded yourself, and willing to share with us, please join us! We would provide the most professional communication platform.

Description

Description 中文：https://www.cansinotech.com.cn/ ； EN：https://www.cansinotech.com/

Description CanSino Biologics Inc. announced that the National Medical Products Administration of China granted conditional marketing authorization for its Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) (“Ad5-nCoV”, trade name: Convidecia™), making it the first of its kind authorized in China.

Description CanSino offers a wide range of opportunities for experienced professionals. Learn about the many ways you can apply your skills to an exciting career at CanSino.If you are interested in becoming part of a leading-edge company, driving your own career and working with outstanding people to deliver sustainable business growth with us, then you’ve come to the right place.

Description Developed COVID-19 vaccine Convidecia; Successfully listed on STAR market of the Shanghai Stock Exchange

Description Obtained NDA approval of Ad5-EBOV in China

Description

Description

Description